HUE052167T2 - Bélben oldódó bevonattal ellátott tabletta - Google Patents

Bélben oldódó bevonattal ellátott tabletta

Info

Publication number
HUE052167T2
HUE052167T2 HUE14754975A HUE14754975A HUE052167T2 HU E052167 T2 HUE052167 T2 HU E052167T2 HU E14754975 A HUE14754975 A HU E14754975A HU E14754975 A HUE14754975 A HU E14754975A HU E052167 T2 HUE052167 T2 HU E052167T2
Authority
HU
Hungary
Prior art keywords
coated tablet
enteric coated
enteric
tablet
coated
Prior art date
Application number
HUE14754975A
Other languages
English (en)
Inventor
Akio Ryu
Miyako Osada
Original Assignee
Zeria Pharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=51391349&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUE052167(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Zeria Pharm Co Ltd filed Critical Zeria Pharm Co Ltd
Publication of HUE052167T2 publication Critical patent/HUE052167T2/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/284Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846Poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • A61K31/606Salicylic acid; Derivatives thereof having amino groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/286Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HUE14754975A 2013-02-22 2014-02-21 Bélben oldódó bevonattal ellátott tabletta HUE052167T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2013032759 2013-02-22

Publications (1)

Publication Number Publication Date
HUE052167T2 true HUE052167T2 (hu) 2021-04-28

Family

ID=51391349

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE14754975A HUE052167T2 (hu) 2013-02-22 2014-02-21 Bélben oldódó bevonattal ellátott tabletta

Country Status (25)

Country Link
US (4) US20150374632A1 (hu)
EP (1) EP2959892B1 (hu)
JP (1) JP6237760B2 (hu)
KR (1) KR102167265B1 (hu)
CN (1) CN105025888B (hu)
AU (1) AU2014219726B2 (hu)
BR (1) BR112015020237B1 (hu)
CA (1) CA2901166C (hu)
CY (1) CY1123908T1 (hu)
DK (1) DK2959892T3 (hu)
ES (1) ES2821766T3 (hu)
HR (1) HRP20201808T1 (hu)
HU (1) HUE052167T2 (hu)
IL (1) IL240575B (hu)
LT (1) LT2959892T (hu)
MX (1) MX369967B (hu)
NZ (1) NZ711201A (hu)
PT (1) PT2959892T (hu)
RS (1) RS61099B1 (hu)
RU (1) RU2675844C2 (hu)
SG (1) SG11201506653WA (hu)
SI (1) SI2959892T1 (hu)
TW (1) TWI688411B (hu)
WO (1) WO2014129568A1 (hu)
ZA (1) ZA201506585B (hu)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107708696B (zh) 2015-06-30 2021-05-28 国立大学法人冈山大学 炎症性肠病的预防或治疗用药剂
EP3162362A1 (de) * 2015-10-30 2017-05-03 Dr. Falk Pharma Gmbh Optimierte mesalazinhaltige hochdosistablette
CN106511277A (zh) * 2016-11-22 2017-03-22 吉林省博大伟业制药有限公司 一种聚普瑞锌颗粒剂及其制备方法
US10098898B1 (en) 2017-12-04 2018-10-16 Handa Pharmaceuticals, Llc Release stable mesalamine dosage forms
EP3662898A1 (en) * 2018-12-07 2020-06-10 Tillotts Pharma AG Solid composition comprising mesalazine

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58109413A (ja) * 1981-12-23 1983-06-29 Eisai Co Ltd 耐衝撃性腸溶錠
US5914132A (en) 1993-02-26 1999-06-22 The Procter & Gamble Company Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
ITMI991316A1 (it) * 1999-06-14 2000-12-14 Cip Ninety Two 92 S A Composizioni farmaceutiche orali a rilascio modificato di mesalazina
DE10013029A1 (de) * 2000-03-17 2001-09-20 Roehm Gmbh Mehrschichtige Arzneiform für die Colonfreigabe
US20020028240A1 (en) * 2000-04-17 2002-03-07 Toyohiro Sawada Timed-release compression-coated solid composition for oral administration
HU231030B1 (hu) * 2001-11-23 2019-12-30 Warner Chilcott Company, Llc Többszörös bevonattal ellátott gyógyszer dózisforma
EP1589951B1 (en) * 2003-01-03 2017-08-09 Supernus Pharmaceuticals, Inc. Use of a mixture of two or more enteric materials to regulate drug release via membrane or matrix for systemic therapeutics
RU2375048C2 (ru) * 2003-07-17 2009-12-10 Д-Р Редди'С Лабораторис Инк. Фармацевтическая композиция с набухающим покрытием
MY147202A (en) 2003-11-26 2012-11-14 Novartis Ag Compositions comprising organic compounds
DE102006035549A1 (de) * 2006-07-27 2008-01-31 Evonik Röhm Gmbh Arzneiform mit mindestens zweischichtiger Trennschicht
SI2152250T1 (sl) 2007-05-07 2020-06-30 Evonik Operations Gmbh Trdne dozirne oblike, ki vsebujejo enterično oplaščenje s pospešenim sproščanjem zdravila
WO2009047802A2 (en) 2007-10-10 2009-04-16 Lupin Limited Novel colon targeted modified release bioadhesive formulation of 5-amino salicylic acid or its salts and metabolites thereof
US20090162434A1 (en) 2007-12-21 2009-06-25 Disphar International Bv Mesalazine tablet
US8329208B2 (en) * 2009-07-28 2012-12-11 Methylation Sciences International Srl Pharmacokinetics of S-adenosylmethionine formulations
CN101732280B (zh) * 2009-10-23 2012-04-18 天津力生制药股份有限公司 一种结肠定位释药的口服制剂
EP2425826A1 (en) 2010-09-01 2012-03-07 Disphar International B.V. Mesalazine tablet having improved dissolution
EP2468264A1 (en) * 2010-12-27 2012-06-27 Laboratorios Liconsa, S.A. Oral pharmaceutical tablet for controled release of mesalazine and process for obtaining it
NO2659881T3 (hu) * 2012-04-30 2018-04-28

Also Published As

Publication number Publication date
WO2014129568A1 (ja) 2014-08-28
BR112015020237A2 (pt) 2017-07-18
CA2901166C (en) 2020-03-24
AU2014219726B2 (en) 2018-03-15
SG11201506653WA (en) 2015-09-29
US20190015345A1 (en) 2019-01-17
CN105025888A (zh) 2015-11-04
KR20150118160A (ko) 2015-10-21
SI2959892T1 (sl) 2020-12-31
BR112015020237B1 (pt) 2022-09-13
CY1123908T1 (el) 2022-03-24
TWI688411B (zh) 2020-03-21
RU2675844C2 (ru) 2018-12-25
MX369967B (es) 2019-11-27
HRP20201808T1 (hr) 2021-01-08
TW201501731A (zh) 2015-01-16
MX2015010871A (es) 2015-12-01
NZ711201A (en) 2019-10-25
RU2015140119A (ru) 2017-03-30
US20150374632A1 (en) 2015-12-31
AU2014219726A1 (en) 2015-09-10
DK2959892T3 (da) 2020-09-21
CN105025888B (zh) 2018-10-12
IL240575B (en) 2020-07-30
PT2959892T (pt) 2020-12-15
EP2959892B1 (en) 2020-09-09
EP2959892A1 (en) 2015-12-30
ZA201506585B (en) 2017-03-29
RS61099B1 (sr) 2020-12-31
RU2015140119A3 (hu) 2018-03-06
LT2959892T (lt) 2020-12-10
JPWO2014129568A1 (ja) 2017-02-02
IL240575A0 (en) 2015-09-24
CA2901166A1 (en) 2014-08-28
KR102167265B1 (ko) 2020-10-19
EP2959892A4 (en) 2016-10-05
US20230372250A1 (en) 2023-11-23
US20210093577A1 (en) 2021-04-01
JP6237760B2 (ja) 2017-11-29
ES2821766T3 (es) 2021-04-27

Similar Documents

Publication Publication Date Title
GB201306312D0 (en) Tablet case
HK1219427A1 (zh) 複合物
HK1217316A1 (zh) 可光配向的物體
ZA201506585B (en) Enteric coated tablet
PL3033205T3 (pl) Agregat powlekający
EP2967936A4 (en) SUSPENDED STENT
IL241350A0 (en) Subprevir tablets
HK1205463A1 (zh) 含有 -羥基- -咪唑- -甲酰胺的片劑
GB201305361D0 (en) Enhanced expression
HUE048496T2 (hu) Kroszpovidont tartalmazó tabletta
EP2971689A4 (en) CONFIGURATION WITH MULTIPLE COATINGS
HK1224197A1 (zh) 度洛西汀腸溶包衣片劑
PL2833346T3 (pl) Przedmiot powleczony
GB201311332D0 (en) Grease-repellent coating
GB201311531D0 (en) Concept six
GB201311548D0 (en) Concept four
HU4589U (en) Capsule
AU355585S (en) A coat
GB201317353D0 (en) Ed
GB201311537D0 (en) Concept sixteen
GB201311463D0 (en) Concept Nine
GB201311534D0 (en) Concept fifteen